Amedeo Smart

Free Medical Literature Service


 

Amedeo

Obstructive Lung Diseases

  Free Subscription

Articles published in
Arch Bronconeumol
    March 2024
  1. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Effect of Comorbidities and Gender Differences in Survival in Patients With Bronchiectasis.
    Arch Bronconeumol. 2024 Mar 2:S0300-2896(24)00055.
    >> Share

  2. VITACCA M, Malovini A, Paneroni M, Spanevello A, et al
    Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2024;60:153-160.
    >> Share

    February 2024
  3. FAIZ A, Wiersma VR, Salzbrunn JB, Brandsma CA, et al
    COPD Patients Display Increased Peripheral Blood Somatic Mutations Which Associate With the Prevalence of Co-morbidities.
    Arch Bronconeumol. 2024;60:119-121.
    >> Share

  4. GIRON MATUTE WI, Ji Z, de Miguel Diez J
    Clinical Trials in COPD: Future Challenges.
    Arch Bronconeumol. 2024;60:75-76.
    >> Share

    January 2024
  5. PALONES E, Garcia-Rivero JL, Cisneros C, Almonacid-Sanchez C, et al
    Methodology Employed to Develop the Airway Mucus Secretion Test (T-SEC): A Questionnaire to Evaluate Airway Mucus Hypersecretion in Patients With Asthma.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00003.
    >> Share

  6. MAKRINIOTI H, Homil K, Hurme P, Erkkola R, et al
    Peripheral Blood MxA Levels During a First Acute Wheezing Episode and the Link to Childhood Asthma.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00001.
    >> Share

  7. BEASLEY R, Ferreira DS, Papi A
    As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.
    Arch Bronconeumol. 2024 Jan 17:S0300-2896(24)00004.
    >> Share

  8. LI W, Dong P, Wang W
    Unveiling the Link between Asthma and Cancer Risk: Shedding New Light through Mendelian Randomization.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00418.
    >> Share

  9. LUNA-PARDO C, Cruz-Chamorro DA, Martinez-Tomas R, Briones-Gomez A, et al
    Endoscopic Lung Volume Reduction With Vapor Ablation in Patients With Severe Emphysema.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00419.
    >> Share

  10. DE-TORRES JP, Alcaide AB, Campo A, Zulueta JJ, et al
    Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience.
    Arch Bronconeumol. 2024 Jan 3:S0300-2896(23)00417.
    >> Share

  11. LOEB E, Zock JP, Miravitlles M, Rodriguez E, et al
    Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population.
    Arch Bronconeumol. 2024;60:16-22.
    >> Share

  12. FIGUEIRA-GONCALVES JM, de Miguel-Diez J
    Initial Treatment in COPD Patients. Do We Take into Account the Severity of the Exacerbation?
    Arch Bronconeumol. 2024;60:65-66.
    >> Share

  13. RIESCO MIRANDA JA, Calle Rubio M, Diaz Perez D, Lopez-Campos JL, et al
    Efficacy and Safety of Single-inhaler Triple Therapy Containing Dual Bronchodilator With Corticosteroids Compared to Monotherapy, Dual Therapy, or Open Triple Therapy in Moderate/Severe COPD: A Systematic Literature Review.
    Arch Bronconeumol. 2024;60:55-58.
    >> Share

  14. DE-TORRES JP, Casanova C, Marin JM, Cabrera C, et al
    Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience.
    Arch Bronconeumol. 2024;60:10-15.
    >> Share

  15. DE MIGUEL-DIEZ J, Figueira-Goncalves JM, Trillo-Calvo E, Cimas-Hernando JE, et al
    Referral Criteria for Chronic Obstructive Pulmonary Disease: A Proposal of Continuity of Care.
    Arch Bronconeumol. 2024;60:7-9.
    >> Share

    December 2023
  16. ORDONEZ LOZANO PA, Ruiz JM, Rey Gutama H
    Large Cystic Bronchiectasis: A Differential Diagnosis.
    Arch Bronconeumol. 2023 Dec 18:S0300-2896(23)00408.
    >> Share

  17. MORENA D, Lumbreras S, Rodriguez JM, Campos C, et al
    Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection.
    Arch Bronconeumol. 2023;59:797-804.
    >> Share

  18. BUSTAMANTE-GUEVARA GV, Iglesias-Serrano I, Camacho Soriano J
    Refractory Inflammatory Plastic Bronchitis in Children and the Use of Mepolizumab as a Treatment.
    Arch Bronconeumol. 2023;59:829-830.
    >> Share

    November 2023
  19. VALVERDE-MONGE M, Sanchez-Carrasco P, Betancor D, Barroso B, et al
    Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
    Arch Bronconeumol. 2023 Nov 22:S0300-2896(23)00379.
    >> Share

  20. CALLE RUBIO M, Miravitlles M, Lopez-Campos JL, Alcazar Navarrete B, et al
    Inhaled Maintenance Therapy in the Follow-Up of COPD in Outpatient Respiratory Clinics. Factors Related to Inhaled Corticosteroid Use. EPOCONSUL 2021 Audit.
    Arch Bronconeumol. 2023;59:725-735.
    >> Share

  21. REY-BRANDARIZ J, Perez-Rios M, Ahluwalia JS, Beheshtian K, et al
    Tobacco Patterns and Risk of Chronic Obstructive Pulmonary Disease: Results From a Cross-Sectional Study.
    Arch Bronconeumol. 2023;59:717-724.
    >> Share

  22. MARTINEZ TOMAS R, Briones-Gomez A, Cases Viedma E
    Bronchoscopy Valves for Lung Volume Reduction: Present and Future.
    Arch Bronconeumol. 2023;59:707-708.
    >> Share

    October 2023
  23. ALMONACID-SANCHEZ C, Garcia-Cosio B, Trisan-Alonso A, Callejas-Gonzalez FJ, et al
    Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population.
    Arch Bronconeumol. 2023 Oct 5:S0300-2896(23)00310.
    >> Share

    September 2023
  24. COHEN D, Osadchy A, Cohen-Hagai K, Jarchowsky Dolberg O, et al
    Bronchiectasis in Subjects With Chronic Lymphocytic Leukemia.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00308.
    >> Share

  25. DE DIEGO DAMIA A, Martinez Valle AM
    Antialarmins in Severe Asthma.
    Arch Bronconeumol. 2023 Sep 29:S0300-2896(23)00303.
    >> Share

  26. RABOSO MORENO B, Calero Pardo S, Abad Fernandez A
    Bardet-Biedl Syndrome: An Uncommon Cause of Bronchiectasis.
    Arch Bronconeumol. 2023 Sep 9:S0300-2896(23)00281.
    >> Share

  27. AUSIN P, Navarrete-Rouco ME
    Multiple Targets, Multiple Pathways, Multiple Strategies in the Treatment of Asthma.
    Arch Bronconeumol. 2023 Sep 6:S0300-2896(23)00279.
    >> Share

    August 2023
  28. PINOT DE MOIRA A, Taylor-Robinson D
    Social Inequalities in Asthma: The Cold Facts.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00263.
    >> Share

  29. PILIA MF, Cruz MJ, Ma D, Romero-Mesones C, et al
    The Role of Inflammatory Phenotype in Patients With Exacerbation-prone Asthma and Ongoing Therapy.
    Arch Bronconeumol. 2023 Aug 5:S0300-2896(23)00264.
    >> Share

  30. DELORME M, Leotard A, Lebret M, Lefeuvre C, et al
    Effect of Intensity of Home Noninvasive Ventilation in Individuals With Neuromuscular and Chest Wall Disorders: A Systematic Review and Meta-Analysis of Individual Participant Data.
    Arch Bronconeumol. 2023;59:488-496.
    >> Share

    July 2023
  31. MARTINEZ-GARCIA MA, Oscullo G, Gomez-Olivas JD, Olveira C, et al
    Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries.
    Arch Bronconeumol. 2023 Jul 27:S0300-2896(23)00261.
    >> Share

  32. CAZZOLA M, Matera MG, Martinez-Garcia MA
    Dual Broncodilator and Triple Therapy in Bronchiectasis. Clinical Trials are Urgently Needed.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00228.
    >> Share

  33. URRUTIA-ROYO B, Garcia-Olive I, Compte M, Folgado C, et al
    Impact of Comorbidities in Clinical Outcomes in Patients Admitted for Exacerbation of Bronchiectasis.
    Arch Bronconeumol. 2023 Jul 22:S0300-2896(23)00234.
    >> Share

  34. DE LA ROSA-CARRILLO D, Maiz-Carro L, Martinez-Garcia MA
    What Have We Learned About Bronchiectasis From RIBRON (Spanish Bronchiectasis Registry)?
    Arch Bronconeumol. 2023 Jul 15:S0300-2896(23)00226.
    >> Share

  35. SALAHUDDIN M, Alavi M, Nasir S
    Invasive Aspergillosis and Pseudomembranous Tracheitis in Uncontrolled Diabetes.
    Arch Bronconeumol. 2023;59:449-450.
    >> Share

  36. BLANCO I, Diego I, Castanon C, Bueno P, et al
    Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:427-434.
    >> Share

  37. FIGUEIRA-GONCALVES JM, Golpe R
    Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations.
    Arch Bronconeumol. 2023;59:412-413.
    >> Share

    June 2023
  38. FIGUEIRA-GONCALVES JM, Hernandez-Perez JM, Cabrera-Lopez C, Wanguemert-Perez AL, et al
    Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease.
    Arch Bronconeumol. 2023;59:403-405.
    >> Share

  39. RODRIGUEZ-SEGADE ALONSO S, Diego Roza C, Marzoa Rivas R, Nieto Codesido I, et al
    Prevalence and Risk Factors for Airflow Limitation in Patients With Acute Coronary Syndrome.
    Arch Bronconeumol. 2023;59:397-400.
    >> Share

  40. LACASSE Y, Maltais F
    When and When Not to Prescribe Home Oxygen in COPD.
    Arch Bronconeumol. 2023;59:350-351.
    >> Share

  41. BETANCOR D, Villalobos-Vilda C, Olaguibel JM, Rodrigo-Munoz JM, et al
    The New ERS/ATS 2022 Bronchodilator Response Recommendation: Comparison With the Previous Version in an Asthma Cohort.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00173.
    >> Share

  42. COSIO BG, Shafiek H, Iglesias A, Mosteiro M, et al
    Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils.
    Arch Bronconeumol. 2023 Jun 1:S0300-2896(23)00172.
    >> Share

    May 2023
  43. GONZALEZ-DE PAZ L, Valdesoiro-Navarrete L, Roma J, Blat-Guimera E, et al
    Prevalence and Impact of Asthma and Allergy on Daily Life, Health Outcomes and Use of Healthcare Services in Children: A Population-Based Study.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00163.
    >> Share

  44. MARTINEZ RIVERA C, Serra Mitja P, Andreo Garcia F, Crespo-Lessmann A, et al
    Factors Associated With Large Airway Collapse in Severe Asthma.
    Arch Bronconeumol. 2023 May 24:S0300-2896(23)00164.
    >> Share

  45. MARTINEZ-MORAGON E
    Cost-Effectiveness of Biologic Therapies in Asthma in Spain.
    Arch Bronconeumol. 2023 May 23:S0300-2896(23)00165.
    >> Share

  46. CALLE RUBIO M, Lopez-Campos JL, Miravitlles M, Soler Cataluna JJ, et al
    Variations in Chronic Obstructive Pulmonary Disease Outpatient Care in Respiratory Clinics: Results From the 2021 EPOCONSUL Audit.
    Arch Bronconeumol. 2023;59:295-304.
    >> Share

  47. GEA J, Enriquez-Rodriguez CJ, Pascual-Guardia S
    Metabolomics in COPD.
    Arch Bronconeumol. 2023;59:311-321.
    >> Share

  48. POLVERINO F, Celli B
    Challenges in the Pharmacotherapy of COPD Subtypes.
    Arch Bronconeumol. 2023;59:284-287.
    >> Share

    April 2023
  49. JIMENEZ-GOMEZ M, Diaz Campos RM, Diab Caceres L
    Cystic Fibrosis-Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00126.
    >> Share

  50. GALAN-NEGRILLO M, Garcia-Pachon E
    Reduction in Hospital Admissions for Asthma and COPD During the First Year of COVID-19 Pandemic in Spain.
    Arch Bronconeumol. 2023 Apr 20:S0300-2896(23)00125.
    >> Share

  51. AGUSTI A, Celli BR, Criner GJ, Halpin D, et al
    Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
    Arch Bronconeumol. 2023;59:232-248.
    >> Share

  52. GONZALEZ J, de Batlle J, Benitez ID, Torres G, et al
    Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients.
    Arch Bronconeumol. 2023;59:205-215.
    >> Share

  53. MARQUEZ CABALLERO J, Cordero Matia ME
    Epidemiology of Acute Bronchiolitis in a Third-level Hospital During the COVID-19 Pandemic.
    Arch Bronconeumol. 2023;59:264-266.
    >> Share

    March 2023
  54. PEREZ-DE-LLANO L, Veiga-Teijeiro I, Dacal-Rivas D
    Contribution of the Remission Concept to the Treatment of Asthma.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00108.
    >> Share

  55. LOBO-REBOLLO MJ, Garcia-Baron C, Villar-Alvarez F
    Acute Hemorrhage into an Emphysematous Bulla.
    Arch Bronconeumol. 2023 Mar 21:S0300-2896(23)00106.
    >> Share

  56. GARCIA CASTILLO E, Alonso Perez T, Pelaez A, Perez Gonzalez P, et al
    Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017.
    Arch Bronconeumol. 2023;59:142-151.
    >> Share

  57. PEREIRA BARROS P, Dos Santos B, Brito U
    Difficult Diagnosis of a Foreign Body Inhalation in a COPD Patient.
    Arch Bronconeumol. 2023;59:172.
    >> Share

  58. MAESTRI R, Vitacca M, Paneroni M, Zampogna E, et al
    Gender and Age as Determinants of Success of Pulmonary Rehabilitation in Individuals With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:174-177.
    >> Share

    February 2023
  59. HERNANDEZ-PEREZ JM, Martin-Gonzalez E, Gonzalez-Carracedo MA
    Alpha-1 Antitrypsin Deficiency and SERPINA1 Variants Could Play a Role in Asthma Exacerbations.
    Arch Bronconeumol. 2023 Feb 28:S0300-2896(23)00038.
    >> Share

  60. ARISMENDI E, Bantula M, Picado C
    Obese Asthma Syndrome: Much Work to Do.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00040.
    >> Share

  61. ALCARAZ-SERRANO V, Sanz-Fraile H, Bueno-Freire L, Farre R, et al
    Association Between Viscoelastic Characteristics and Sputum Colour in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Feb 25:S0300-2896(23)00039.
    >> Share

  62. PASCUAL-GUARDIA S, Amati F, Marin-Corral J, Aliberti S, et al
    Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
    Arch Bronconeumol. 2023;59:90-100.
    >> Share

  63. LOPEZ-CAMPOS JL, Caballero Eraso C
    Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: So Far, So Good.
    Arch Bronconeumol. 2023;59:71-72.
    >> Share

  64. LOPEZ-PARDO ME, Candal-Pedreira C, Valdes-Cuadrado L, Represas-Represas C, et al
    Factors Linked to Frequent Attendance in the Out-of-hospital Setting by Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2023;59:119-122.
    >> Share

    January 2023
  65. MATABUENA M, Salgado FJ, Nieto-Fontarigo JJ, Alvarez-Puebla MJ, et al
    Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00012.
    >> Share

  66. ALIBERTI S, Gramegna A, Seia M, Malvestiti F, et al
    Alpha(1)-Antitrypsin Inherited Variants in Patients With Bronchiectasis.
    Arch Bronconeumol. 2023 Jan 18:S0300-2896(23)00009.
    >> Share

  67. LUJAN M
    Home High-Flow Oxygen Therapy Should Be Considered in Patients With COPD and Chronic Respiratory Failure.
    Arch Bronconeumol. 2023;59:5-6.
    >> Share

  68. PALONES E, Curto E, Pelegri A, Arilla M, et al
    Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia.
    Arch Bronconeumol. 2023;59:63-65.
    >> Share

  69. SCICLUNA V, Han M
    COPD in Women: Future Challenges.
    Arch Bronconeumol. 2023;59:3-4.
    >> Share

  70. AMADO DIAGO CA, Figueira Goncalves JM, Golpe R, Esteban C, et al
    Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria.
    Arch Bronconeumol. 2023;59:57-58.
    >> Share

    December 2022
  71. NIGRO M, Simonetta E, Martinez-Garcia MA, Aliberti S, et al
    Biologics in Bronchiectasis: A Future Treatment?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00671.
    >> Share

  72. ZHAO N, Suissa S, Ernst P
    Beta-agonist Use and Increased Asthma Mortality: Reality or Fiction?
    Arch Bronconeumol. 2022 Dec 23:S0300-2896(22)00669.
    >> Share

  73. PIOCH CO, Connell DW, Shoemark A
    Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future Challenges.
    Arch Bronconeumol. 2022 Dec 18:S0300-2896(22)00663.
    >> Share

  74. GALERA R, Mergelina C, Casitas R, Martinez-Ceron E, et al
    Increased Blood Eosinophil Count Is Related to Less Daily Physical Activity in Patients With Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:837-839.
    >> Share

  75. LIANG Y, Sun Y
    COPD in China: Current Status and Challenges.
    Arch Bronconeumol. 2022;58:790-791.
    >> Share

    November 2022
  76. CHANG AB, Kantar A, Redding GJ, Hill AT, et al
    Is Bronchiectasis a Reversible Disorder?
    Arch Bronconeumol. 2022 Nov 19:S0300-2896(22)00633.
    >> Share

  77. MADRID CARBAJAL C, Palomo B, Garcia Clemente M
    Radiological Changes After Treatment With Triple Therapy in Cystic Fibrosis. Are Bronchiectasis Irreversible?
    Arch Bronconeumol. 2022 Nov 5:S0300-2896(22)00599.
    >> Share

  78. CALLE RUBIO M, Lopez-Campos JL, Izquierdo Alonso JL, Martinez Pitarch D, et al
    Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group.
    Arch Bronconeumol. 2022;58:776-779.
    >> Share

  79. ROMERO-FALCON MA, Medina-Gallardo JF, Lopez-Campos JL, Maestre Sanchez MV, et al
    Evaluation of the Diagnostic Accuracy of Non-Specific Bronchial Provocation Tests in the Diagnosis of Asthma: A Randomized Cross-Over Study.
    Arch Bronconeumol. 2022 Nov 1. pii: S0300-2896(22)00596.
    >> Share

    October 2022
  80. FIGUEIRA-GONCALVES JM, Golpe R
    Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients.
    Arch Bronconeumol. 2022;58:729-730.
    >> Share

  81. MONTEAGUDO M, Nunez A, Barrecheguren M, Miravitlles M, et al
    Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based Study.
    Arch Bronconeumol. 2022;58:699-707.
    >> Share

  82. MARTIN-ONTIYUELO C, Rodo-Pin A, Echeverria-Esnal D, Admetllo M, et al
    Intravenous Iron Replacement Improves Exercise Tolerance in COPD: A Single-Blind Randomized Trial.
    Arch Bronconeumol. 2022;58:689-698.
    >> Share

    September 2022
  83. ALVAREZ-GUTIERREZ FJ, Blanco-Aparicio M, Casas-Maldonado F, Plaza V, et al
    What's New in the 2022 Consensus for Severe Asthma in Adults.
    Arch Bronconeumol. 2022 Sep 28. pii: S0300-2896(22)00575.
    >> Share

  84. DIAB CACERES L, Morales Ruiz R, Villena Garrido V
    Does Bronchiectasis Cause Irreversible Damage?
    Arch Bronconeumol. 2022 Sep 27. pii: S0300-2896(22)00576.
    >> Share

  85. SOLARAT B, Perea L, Faner R, de La Rosa D, et al
    Pathophysiology of Chronic Bronchial Infection in Bronchiectasis.
    Arch Bronconeumol. 2022 Sep 15. pii: S0300-2896(22)00525.
    >> Share

  86. SADATSAFAVI M, Aaron SD, Gershon AS, Puhan M, et al
    The Hidden and Unchecked Judgement Calls When Using Exacerbation History for Managing COPD.
    Arch Bronconeumol. 2022;58:629-631.
    >> Share

  87. GONZALEZ J, Carmona P, Gracia-Lavedan E, Benitez ID, et al
    Cluster Analysis of Home Mechanical Ventilation in COPD Patients: A Picture of the Real World and Its Impact on Mortality.
    Arch Bronconeumol. 2022;58:642-648.
    >> Share

  88. RODRIGO-TROYANO A, Giner J, Perea L, Merino JL, et al
    Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose.
    Arch Bronconeumol. 2022;58:663-665.
    >> Share

    August 2022
  89. COSIO BG, Shafiek H, Martinez-Garcia MA
    Is it Time to Readjust the Doses of Inhaled Corticosteroids in COPD?
    Arch Bronconeumol. 2022;58:593-594.
    >> Share

  90. ALCAZAR-NAVARRETE B, Diaz-Lopez JM, Garcia-Flores P, Ortega-Antelo M, et al
    T2 Biomarkers as Predictors of Exacerbations of Chronic Obstructive Pulmonary Disease.
    Arch Bronconeumol. 2022;58:595-600.
    >> Share

  91. SU KC, Ko HK, Hsiao YH, Chou KT, et al
    Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Arch Bronconeumol. 2022;58:601-610.
    >> Share

  92. SORIANO JB, Dai X, Ancochea J
    An Euler Proportional Venn Diagram of Obstructive Lung Disease.
    Arch Bronconeumol. 2022;58:627-628.
    >> Share

    July 2022
  93. KUNADHARAJU R, Rudraraju A, Sethi S
    Pseudomonas aeruginosa Colonization and COPD: The Chicken or the Egg?
    Arch Bronconeumol. 2022;58:539-541.
    >> Share

    June 2022
  94. XU JF, Gao YH, Guan WJ
    Advances in Bronchiectasis Registries: The New Chinese Registry.
    Arch Bronconeumol. 2022 Jun 11. pii: S0300-2896(22)00447.
    >> Share

  95. KATSOULIS K, Kipourou M, Quaranta Vitaliano N, Kostikas K, et al
    Predicting Bronchial Hyperresponsiveness in Patients with Asthma: The Role of Impulse Oscillometry.
    Arch Bronconeumol. 2022 Jun 2. pii: S0300-2896(22)00438.
    >> Share

  96. LONG MB, Chalmers JD
    Treating Neutrophilic Inflammation in Airways Diseases.
    Arch Bronconeumol. 2022;58:463-465.
    >> Share

  97. MANISCALCO M, Fuschillo S, Ambrosino P, D'Anna SE, et al
    Bronchodilator Response as a Possible Predictor of Lung Function Improvement After Pulmonary Rehabilitation in Post-COVID-19 Patients.
    Arch Bronconeumol. 2022;58:517-519.
    >> Share

  98. LUIS IZQUIERDO J, Casanova C, Celli B, Santos S, et al
    The 7 Cardinal Sins of COPD in Spain.
    Arch Bronconeumol. 2022;58:498-503.
    >> Share

  99. GARCIA-VALERO J, Olloquequi J, Rodriguez E, Martin-Satue M, et al
    Decreased Expression of EC-SOD and Fibulin-5 in Alveolar Walls of Lungs From COPD Patients.
    Arch Bronconeumol. 2022;58:482-489.
    >> Share

  100. MARCOS PJ, Represas Represas C, Ramos C, Cimadevila Alvarez B, et al
    Impact of a Home Telehealth Program After a Hospitalized COPD Exacerbation: A Propensity Score Analysis.
    Arch Bronconeumol. 2022;58:474-481.
    >> Share

    May 2022
  101. PASCUAL S, Dorado S, Urrutia I
    Physical Activity and Asthma.
    Arch Bronconeumol. 2022 May 17. pii: S0300-2896(22)00342.
    >> Share

  102. SCIOSCIA G, Alcaraz-Serrano V, Mendez R, Gabarrus A, et al
    Factors Associated With One-Year Mortality in Hospitalised Patients With Exacerbated Bronchiectasis.
    Arch Bronconeumol. 2022 May 13. pii: S0300-2896(22)00336.
    >> Share

  103. MARTINEZ-GONZALEZ C, Garcia JA, Blanco I
    [Translated article] Term Pregnancy in a Patient With Severe Pulmonary Emphysema Associated With Pi*ZZ Alpha-1 Antitrypsin Deficiency.
    Arch Bronconeumol. 2022 May 5. pii: S0300-2896(22)00311.
    >> Share

  104. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    [Translated article] Asthma Also Exists in Older People.
    Arch Bronconeumol. 2022 May 4. pii: S0300-2896(22)00312.
    >> Share

  105. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    [Translated article] Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:T451-T453.
    >> Share

  106. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:412-417.
    >> Share

  107. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    [Translated article] Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:T433.
    >> Share

  108. RODRIGUEZ C, Solier A, Marin M, Tenes A, et al
    [Translated article] Prognostic Significance of Findings on CTPA Supporting an Alternative Diagnosis to PE Among Patients Hospitalized for an Exacerbation of COPD: Predefined Subanalysis of the SLICE Trial.
    Arch Bronconeumol. 2022;58:T412-T417.
    >> Share

  109. PEREZ PEREZ JL, Garcia-Manso IG, Garcia Sevila R
    [Translated article] Acute Fibrinous and Organizing Pneumonia Associated With Immunotherapy (Pembrolizumab).
    Arch Bronconeumol. 2022;58:T425-T426.
    >> Share

  110. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    [Translated article] With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:T386-T387.
    >> Share

  111. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    [Translated article] Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:T454-T456.
    >> Share

  112. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:442-443.
    >> Share

  113. FOSCHINI G, Rodriguez CM, Rubio MM, Baldo X, et al
    Placental Transmogrification of the Lung.
    Arch Bronconeumol. 2022;58:433.
    >> Share

  114. GONZALEZ-BARCALA FJ, Martinez-Torres AE, Mendez-Brea P, Garcia-Marcos L, et al
    With the Torch in the Mist of the United Airway Disease: Atopic March and Other Arguments in the Search for Evidence.
    Arch Bronconeumol. 2022;58:386-387.
    >> Share

  115. HU-YANG C, Perez-Fernandez V, Andreu Rodriguez AL, Andujar Espinosa R, et al
    [Translated article] FEV1/FVC Cut-off Values for the Diagnosis of Airflow Obstruction in Pediatric Patients: The Pediatric Airflow Obstruction (PAO) Study.
    Arch Bronconeumol. 2022;58:T442-T443.
    >> Share

  116. DIAZ-PENA R, Julia RF, Montes JF, Silva RS, et al
    Polymorphisms in the FRMD4A Gene Are Associated With Chronic Obstructive Pulmonary Disease Susceptibility in a Latin American Population.
    Arch Bronconeumol. 2022;58:454-456.
    >> Share

  117. GOLPE R, Figueira-Goncalves JM, Esteban C, Amado-Diago CA, et al
    Relationship Between the GesEPOC 2021 Classification of Risk Levels and Phenotypes and the Incidence of Adverse Events.
    Arch Bronconeumol. 2022;58:451-453.
    >> Share

    April 2022
  118. NAVAS-BUENO B, Casas-Maldonado F, Padilla-Galo A, Gonzalez-Moya-Mondelo E, et al
    High Adherence, Microbiological Control and Reduced Exacerbations in Patients With Non-Cystic Fibrosis Bronchiectasis Treated With Nebulised Colistin. A Prospective Observational Study.
    Arch Bronconeumol. 2022 Apr 27. pii: S0300-2896(22)00320.
    >> Share

  119. CHINER-VIVES E, Cordovilla-Perez R, de la Rosa-Carrillo D, Garcia-Clemente M, et al
    Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases.
    Arch Bronconeumol. 2022;58 Suppl 1:39-50.
    >> Share

  120. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    [Translated article] The ANTES Program in COPD: First Year.
    Arch Bronconeumol. 2022;58:T291-T294.
    >> Share

  121. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    [Translated article] Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria With GOLD 2021?
    Arch Bronconeumol. 2022;58:T364-T366.
    >> Share

  122. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:334-344.
    >> Share

  123. MACHUCA AGUADO J, Sabariego-Arenas I, Idoate MA
    A Pulmonary Inflammatory Chondroid Hamartoma With So-called Placental Transmogrification Feature in a Pleural Location. Pathogenic Considerations About This Unusual Disorder.
    Arch Bronconeumol. 2022;58:363.
    >> Share

  124. FIGUEIRA GONCALVES JM, Golpe R, Esteban C, Amado Diago C, et al
    Initial Treatment in Chronic Obstructive Pulmonary Disease According to GesEPOC 2021 vs. GesEPOC 2017. Approaching Criteria with GOLD 2021?
    Arch Bronconeumol. 2022;58:364-366.
    >> Share

  125. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:345-351.
    >> Share

  126. AGUSTI A, Alcazar B, Ancochea J, Casanova C, et al
    The ANTES program in COPD: First year.
    Arch Bronconeumol. 2022;58:291-294.
    >> Share

  127. COSIO BG, Hernandez C, Chiner E, Gimeno-Santos E, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC 2021): Non-pharmacological Treatment Update.
    Arch Bronconeumol. 2022;58:T345-T351.
    >> Share

  128. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    [Translated article] Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:T323-T333.
    >> Share

  129. GARCIA-RIO F, Alcazar-Navarrete B, Castillo-Villegas D, Cilloniz C, et al
    Biological Biomarkers in Respiratory Diseases.
    Arch Bronconeumol. 2022;58:323-333.
    >> Share

  130. LOPEZ-CAMPOS JL, Almagro P, Gomez JT, Chiner E, et al
    [Translated article] Spanish COPD Guideline (GesEPOC) Update: Comorbidities, Self-Management and Palliative Care.
    Arch Bronconeumol. 2022;58:T334-T344.
    >> Share

    March 2022
  131. PERPINA TORDERA M, Alvarez Gutierrez FJ, Blanco Aparicio M
    Asthma also exists in older people.
    Arch Bronconeumol. 2022 Mar 11. pii: S0300-2896(22)00183.
    >> Share

    February 2022
  132. MARTINEZ-GONZALEZ C, Adanez Garcia J, Blanco I
    Term pregnancy of a patient with severe pulmonary emphysema associated with (PI*ZZ) alpha-1 antitrypsin.
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00094.
    >> Share

  133. BARALDI F, Alfano F, Contoli M, Papi A, et al
    Small Airway Disease in Asthma: Why is it so Important?
    Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00093.
    >> Share

  134. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    >> Share

  135. CAZZOLA M, Rogliani P, Matera MG
    The Future of Bronchodilators in COPD and Asthma.
    Arch Bronconeumol. 2022;58:107-108.
    >> Share

  136. SOLER-CATALUNA JJ, Pinera P, Trigueros JA, Calle M, et al
    [Translated article] Spanish COPD Guidelines (GesEPOC) 2021 Update. Diagnosis and Treatment of COPD Exacerbation Syndrome.
    Arch Bronconeumol. 2022;58:T159-T170.
    >> Share

  137. PLAZA V, Alobid I, Alvarez C, Blanco M, et al
    [Translated article] Spanish Asthma Management Guidelines (GEMA) v.5.1. Highlights and Controversies.
    Arch Bronconeumol. 2022;58:T150-T158.
    >> Share

    January 2022
  138. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes.
    Arch Bronconeumol. 2022;58:35-51.
    >> Share

    December 2021
  139. MARTINEZ-GARCIA MA, Aksamit TR, Aliberti S
    Bronchiectasis as a Long-Term Consequence of SARS-COVID-19 Pneumonia: Future Studies are Needed.
    Arch Bronconeumol. 2021;57:739-740.
    >> Share

  140. FIGUEIRA GONCALVES JM, Golpe R, Ramallo Y, Garcia Talavera I, et al
    Should pulse oximeter saturations be included in the risk stratification for chronic obstructive pulmonary disease proposed by GesEPOC?
    Arch Bronconeumol. 2021;57:774-776.
    >> Share

  141. CALLE RUBIO M, Rodriguez Hermosa JL, Miravitlles M, Lopez-Campos JL, et al
    Knowledge of chronic obstructive pulmonary disease, presence of chronic respiratory symptoms and use of spirometry among the Spanish population: CONOCEPOC 2019 study.
    Arch Bronconeumol. 2021;57:741-749.
    >> Share

  142. VAZQUEZ-MERA S, Pichel JG, Salgado FJ
    Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players.
    Arch Bronconeumol. 2021;57:731-732.
    >> Share

    November 2021
  143. OJANGUREN I, Satia I, Usmani OS
    The Role of Viral Infections on Severe Asthma Exacerbations: Present and Future.
    Arch Bronconeumol. 2021 Nov 1. pii: S0300-2896(21)00350.
    >> Share

  144. LOPEZ-ALBA A, Aldao-Arguelles I, de Granda-Orive JI
    Plastic bronchitis and Noonan syndrome.
    Arch Bronconeumol. 2021;57:705.
    >> Share

  145. FERREIRO A, Granados G, Villar A
    Peribronchovascular emphysema. The Macklin effect.
    Arch Bronconeumol. 2021;57:697.
    >> Share

  146. DE-TORRES JP, Wisnivesky JP
    Lung Cancer Screening in Patients With Chronic Obstructive Pulmonary Disease: Do the Benefits Outweigh the Risks?
    Arch Bronconeumol. 2021;57:679-680.
    >> Share

  147. MARTINEZ-GARCIA MA
    Bronchiectasis and Eosinophils.
    Arch Bronconeumol. 2021;57:671-672.
    >> Share

    October 2021
  148. PEREZ-TORRES LOBATO MR, Mejias Trueba M, Rodriguez Ramallo H, Alvarez Del Vayo Benito C, et al
    Prolonged treatment with inhaled ampicillin in children with non-cystic fibrosis bronchiectasis.
    Arch Bronconeumol. 2021;57:662-664.
    >> Share

  149. RUANO-RAVINA A, Cameselle-Lago C, Torres-Duran M, Pando-Sandoval A, et al
    Indoor Radon Exposure and COPD, Synergic Association? A Multicentric, Hospital-Based Case-Control Study in a Radon-Prone Area.
    Arch Bronconeumol. 2021;57:630-636.
    >> Share

  150. SUEHS CM, Bourdin A
    Tapering of Oral Corticosteroids for the Treatment of Asthma.
    Arch Bronconeumol. 2021;57:621-622.
    >> Share

  151. COHEN M, Casas A, Zabert G, Torres-Duque CA, et al
    Updated Strategic Plan of the Latin American Thoracic Association (ALAT). "The ten commandments for 2021-2026 quinquennial".
    Arch Bronconeumol. 2021;57:617-620.
    >> Share

  152. MARTINEZ-VERGARA A, Giron RM, Churruca-Arrospide M, Lopez-Pereira P, et al
    Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation.
    Arch Bronconeumol. 2021;57:664-666.
    >> Share

    September 2021
  153. ALCARAZ-SERRANO V, Lee AL, Gimeno-Santos E
    Respiratory Physiotherapy and Bronchiectasis.
    Arch Bronconeumol. 2021 Sep 14. pii: S0300-2896(21)00316.
    >> Share

  154. BLANCO-CONDE S, Gonzalez-Cortes C, Lopez-Medrano R, Carazo-Fernandez L, et al
    Mycobacterium abscessus Infected Neutrophils as an In Vitro Model for Bronchiectasis. Neutrophils Prevent Mycobacterial Aggregation.
    Arch Bronconeumol. 2021 Sep 4. pii: S0300-2896(21)00231.
    >> Share

  155. ANDUJAR-ESPINOSA R, Salinero-Gonzalez L
    Vitamin D supplementation: A treatment with possible benefits in asthma.
    Arch Bronconeumol. 2021;57:567-568.
    >> Share

  156. GOLPE R, Dacal-Rivas D, Blanco-Cid N, Castro-Anon O, et al
    Need for Epidemiological Studies on Chronic Obstructive Pulmonary Disease in Rural Spain.
    Arch Bronconeumol. 2021;57:614-615.
    >> Share

  157. CARRASCO HERNANDEZ L, Caballero Eraso C, Abad Arranz M, Marquez Martin E, et al
    Time-based Register and Analysis of COPD Endpoints (TRACE) Project: Methodology and Workflow.
    Arch Bronconeumol. 2021;57:593-594.
    >> Share

  158. COSIO BG, Shafiek H, Verdu J, Fiorentino F, et al
    Implementation of an Integrated Care Model for Frequent-Exacerbator COPD Patients: A Controlled Prospective Study.
    Arch Bronconeumol. 2021;57:577-583.
    >> Share

  159. ALONSO-PEREZ T, Garcia-Castillo E, Lopez-Campos JL
    Escalation and de-escalation of therapy in chronic obstructive pulmonary disease. Is the inhaler important?
    Arch Bronconeumol. 2021;57:604-605.
    >> Share

  160. LOPEZ-CAMPOS JL, Calle Rubio M, Izquierdo Alonso JL, Fernandez-Villar A, et al
    Forum COPD working group consensus on the diagnosis, treatment and follow-up of COPD.
    Arch Bronconeumol. 2021;57:596-599.
    >> Share

    August 2021
  161. EZPONDA A, Casanova C, Cabrera C, Martin-Palmero A, et al
    Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients.
    Arch Bronconeumol. 2021;57:533-539.
    >> Share

  162. MOROLI RG, Santos DOD, Souza HCD, Perossi L, et al
    Effects of Controlled Voluntary Increase in the Ventilatory Demand on Respiratory System Resistance in Healthy and Non-Cystic Fibrosis Bronchiectasis Subjects: A Cross-Sectional Study.
    Arch Bronconeumol. 2021;57:528-532.
    >> Share

  163. GARCIA-SANZ MT, Gonzalez-Barcala FJ
    COPD is more than just lung function: Let's not forget depression.
    Arch Bronconeumol. 2021;57:519-520.
    >> Share

    July 2021
  164. MCDONALD VM, Gibson PG
    Treatable Traits in Asthma and COPD.
    Arch Bronconeumol. 2021 Jul 16. pii: S0300-2896(21)00206.
    >> Share

  165. LOPEZ-VILLARRUBIA E, Costa Estirado O, Iniguez Hernandez C, Ballester Diez F, et al
    Do Saharan Dust Days Carry a Risk of Hospitalization From Respiratory Diseases for Citizens of the Canary Islands (Spain)?
    Arch Bronconeumol. 2021;57:464-470.
    >> Share

    June 2021
  166. MARCHIORI E, Souza Rodrigues R, Menna Barreto M
    Exuberant Paraseptal Emphysema Associated With Pulmonary Alveolar Microlithiasis: 12 Years of Evolution.
    Arch Bronconeumol. 2021 Jun 24. pii: S0300-2896(21)00196.
    >> Share

    April 2021
  167. SAWAMURA MVY, Athanazio RA, Nucci MCNTM, Rached SZ, et al
    Automated Computed Tomography Lung Densitometry in Bronchiectasis Patients.
    Arch Bronconeumol. 2021 Apr 25. pii: S0300-2896(21)00136.
    >> Share

    January 2021
  168. ALMONACID C, Blanco-Aparicio M, Dominguez-Ortega J, Giner J, et al
    [Teleconsultation in the follow-up of the asthma patient. Lessons after COVID-19].
    Arch Bronconeumol. 2021;57:13-14.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016